SAN

80.79

+2.1%↑

UCB

272.5

-0.58%↓

SHL.DE

38.22

+1.25%↑

ARGX

705.8

+3.89%↑

VIE

35.35

+2.46%↑

SAN

80.79

+2.1%↑

UCB

272.5

-0.58%↓

SHL.DE

38.22

+1.25%↑

ARGX

705.8

+3.89%↑

VIE

35.35

+2.46%↑

SAN

80.79

+2.1%↑

UCB

272.5

-0.58%↓

SHL.DE

38.22

+1.25%↑

ARGX

705.8

+3.89%↑

VIE

35.35

+2.46%↑

SAN

80.79

+2.1%↑

UCB

272.5

-0.58%↓

SHL.DE

38.22

+1.25%↑

ARGX

705.8

+3.89%↑

VIE

35.35

+2.46%↑

SAN

80.79

+2.1%↑

UCB

272.5

-0.58%↓

SHL.DE

38.22

+1.25%↑

ARGX

705.8

+3.89%↑

VIE

35.35

+2.46%↑

Search

Carl Zeiss Meditec AG

Cerrado

SectorSanidad

27.18 4.62

Resumen

Variación precio

24h

Actual

Mínimo

25.98

Máximo

27.26

Métricas clave

By Trading Economics

Ingresos

52M

80M

Ventas

-161M

467M

P/B

Media del Sector

15.429

66.418

BPA

0.03

Rentabilidad por dividendo

2.21

Margen de beneficios

12.778

Empleados

5,784

EBITDA

124M

187M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+16.3% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.21%

2.36%

Próximas Ganancias

12 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.3B

2.2B

Apertura anterior

22.56

Cierre anterior

27.18

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

96 / 348 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Carl Zeiss Meditec AG Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 abr 2026, 23:25 UTC

Noticias de Eventos Importantes

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13 abr 2026, 22:45 UTC

Noticias de Eventos Importantes

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13 abr 2026, 18:03 UTC

Ganancias

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13 abr 2026, 23:58 UTC

Ganancias

Review & Preview: Earnings Time -- Barrons.com

13 abr 2026, 23:49 UTC

Charlas de Mercado

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13 abr 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13 abr 2026, 23:20 UTC

Charlas de Mercado

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13 abr 2026, 23:01 UTC

Ganancias

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13 abr 2026, 23:01 UTC

Ganancias

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13 abr 2026, 23:01 UTC

Ganancias

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13 abr 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13 abr 2026, 21:26 UTC

Noticias de Eventos Importantes

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13 abr 2026, 21:23 UTC

Ganancias

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13 abr 2026, 21:16 UTC

Ganancias

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

13 abr 2026, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

13 abr 2026, 20:34 UTC

Ganancias

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13 abr 2026, 20:34 UTC

Ganancias

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13 abr 2026, 20:34 UTC

Ganancias

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13 abr 2026, 19:59 UTC

Charlas de Mercado

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13 abr 2026, 19:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13 abr 2026, 19:27 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Correction to Precious Metals Market Talk on April 9

13 abr 2026, 19:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13 abr 2026, 18:59 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13 abr 2026, 18:59 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13 abr 2026, 18:43 UTC

Charlas de Mercado

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Comparación entre iguales

Cambio de precio

Carl Zeiss Meditec AG previsión

Precio Objetivo

By TipRanks

16.3% repunte

Estimación a 12 Meses

Media 30.54 EUR  16.3%

Máximo 46 EUR

Mínimo 22.4 EUR

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Carl Zeiss Meditec AG Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

10 ratings

0

Comprar

9

Mantener

1

Vender

Puntuación técnica

By Trading Central

58.75 / 60.35Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

96 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
help-icon Live chat